Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Clinical trial NCT03588884 · COMPLETED

Trial details

NCT number: NCT03588884
Sponsor: OPKO Health, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism Due to Renal Causes Vitamin D Insufficiency CKD Stage 3 CKD Stage 4

Start date: 2018-06-08
Primary completion: 2020-04-24
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.